Literature DB >> 7541938

FRAXE expansion is not a common etiological factor among developmentally delayed males.

D J Allingham-Hawkins1, P N Ray.   

Abstract

Expansion of a (CGG)n trinucleotide repeat unit at FRAXE, a newly defined fragile site distal to FRAXA, at Xq28, is reported to be associated with mild mental retardation. Three hundred developmentally delayed male patients referred for fragile X testing but negative for the FMR-1 gene trinucleotide expansion were screened for the FRAXE expansion. This group of patients had a wide range of intellectual or behavioral problems and included 19 patients who had low-level fragile site expression detected cytogenetically at Xq27-q28. None of the patients tested positive for the FRAXE expansion. These results suggest that FRAXE is not a common etiological factor among this group of patients. The data support the hypothesis that FRAXE is either very rare or a benign fragile site that is not associated with any clinical phenotype, similar to the FRAXF and FRA16A sites.

Entities:  

Mesh:

Year:  1995        PMID: 7541938      PMCID: PMC1801229     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  10 in total

1.  Fragile sites on human chromosomes: demonstration of their dependence on the type of tissue culture medium.

Authors:  G R Sutherland
Journal:  Science       Date:  1977-07-15       Impact factor: 47.728

2.  A marker X chromosome.

Authors:  H A Lubs
Journal:  Am J Hum Genet       Date:  1969-05       Impact factor: 11.025

3.  Identification of the FRAXE fragile site in two families ascertained for X linked mental retardation.

Authors:  G A Flynn; M C Hirst; S J Knight; J N Macpherson; J C Barber; A V Flannery; K E Davies; V J Buckle
Journal:  J Med Genet       Date:  1993-02       Impact factor: 6.318

4.  Isolation of a GCC repeat showing expansion in FRAXF, a fragile site distal to FRAXA and FRAXE.

Authors:  J E Parrish; B A Oostra; A J Verkerk; C S Richards; J Reynolds; A S Spikes; L G Shaffer; D L Nelson
Journal:  Nat Genet       Date:  1994-11       Impact factor: 38.330

5.  Triplet repeat expansion at the FRAXE locus and X-linked mild mental handicap.

Authors:  S J Knight; M A Voelckel; M C Hirst; A V Flannery; A Moncla; K E Davies
Journal:  Am J Hum Genet       Date:  1994-07       Impact factor: 11.025

6.  Implications of FRA16A structure for the mechanism of chromosomal fragile site genesis.

Authors:  J K Nancarrow; E Kremer; K Holman; H Eyre; N A Doggett; D Le Paslier; D F Callen; G R Sutherland; R I Richards
Journal:  Science       Date:  1994-06-24       Impact factor: 47.728

7.  FMR1 protein: conserved RNP family domains and selective RNA binding.

Authors:  C T Ashley; K D Wilkinson; D Reines; S T Warren
Journal:  Science       Date:  1993-10-22       Impact factor: 47.728

8.  Trinucleotide repeat amplification and hypermethylation of a CpG island in FRAXE mental retardation.

Authors:  S J Knight; A V Flannery; M C Hirst; L Campbell; Z Christodoulou; S R Phelps; J Pointon; H R Middleton-Price; A Barnicoat; M E Pembrey
Journal:  Cell       Date:  1993-07-16       Impact factor: 41.582

9.  Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox.

Authors:  Y H Fu; D P Kuhl; A Pizzuti; M Pieretti; J S Sutcliffe; S Richards; A J Verkerk; J J Holden; R G Fenwick; S T Warren
Journal:  Cell       Date:  1991-12-20       Impact factor: 41.582

10.  Characterisation of a new rare fragile site easily confused with the fragile X.

Authors:  G R Sutherland; E Baker
Journal:  Hum Mol Genet       Date:  1992-05       Impact factor: 6.150

  10 in total
  8 in total

1.  A study of FRAXE in mentally retarded individuals referred for fragile X syndrome (FRAXA) testing in the United Kingdom.

Authors:  S J Knight; R J Ritchie; L Chakrabarti; G Cross; G R Taylor; R F Mueller; J Hurst; J Paterson; J R Yates; D J Dow; K E Davies
Journal:  Am J Hum Genet       Date:  1996-05       Impact factor: 11.025

2.  Fragile X syndrome is less common than previously estimated.

Authors:  J E Morton; S Bundey; T P Webb; F MacDonald; P M Rindl; S Bullock
Journal:  J Med Genet       Date:  1997-01       Impact factor: 6.318

3.  The FRAXE Syndrome: is it time for routine screening?

Authors:  W T Brown
Journal:  Am J Hum Genet       Date:  1996-05       Impact factor: 11.025

4.  FRAXA and FRAXE: the results of a five year survey.

Authors:  S A Youings; A Murray; N Dennis; S Ennis; C Lewis; N McKechnie; M Pound; A Sharrock; P Jacobs
Journal:  J Med Genet       Date:  2000-06       Impact factor: 6.318

5.  Impaired conditioned fear and enhanced long-term potentiation in Fmr2 knock-out mice.

Authors:  Yanghong Gu; Kellie L McIlwain; Edwin J Weeber; Takanori Yamagata; Bisong Xu; Barbara A Antalffy; Christine Reyes; Lisa Yuva-Paylor; Dawna Armstrong; Huda Zoghbi; J David Sweatt; Richard Paylor; David L Nelson
Journal:  J Neurosci       Date:  2002-04-01       Impact factor: 6.167

6.  Expansion and methylation status at FRAXE can be detected on EcoRI blots used for FRAXA diagnosis: analysis of four FRAXE families with mild mental retardation in males.

Authors:  V Biancalana; L Taine; J C Bouix; S Finck; A Chauvin; H De Verneuil; S J Knight; C Stoll; D Lacombe; J L Mandel
Journal:  Am J Hum Genet       Date:  1996-10       Impact factor: 11.025

7.  Autism spectrum disorder: FRAXE mutation, a rare etiology.

Authors:  F Correia; C Café; J Almeida; S Mouga; G Oliveira
Journal:  J Autism Dev Disord       Date:  2015-03

8.  Distribution of FMR1 and FMR2 Repeats in Argentinean Patients with Primary Ovarian Insufficiency.

Authors:  Lucía Daniela Espeche; Violeta Chiauzzi; Ianina Ferder; Mehrnoosh Arrar; Andrea Paula Solari; Carlos David Bruque; Marisol Delea; Susana Belli; Cecilia Soledad Fernández; Noemí Delia Buzzalino; Eduardo Hernán Charreau; Liliana Beatriz Dain
Journal:  Genes (Basel)       Date:  2017-08-16       Impact factor: 4.096

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.